Armata extends credit maturity to June 2027 and warrants to Jan 2031 with Innoviva affiliate

Armata Pharmaceuticals, Inc.

• Maturity of four credit agreements with Innoviva Sub extended to June 1, 2027.
• Expiration of four warrants to purchase ~10.65M shares extended to January 26, 2031.
• Voting agreement termination date extended to earlier of Jan 2031 or FDA approval of any product candidate.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.